Insurers Blast CMS Transparency Rule; ACHP Offers Alternative
March
2
Organizations representing health insurers are blasting the Trump administration’s proposed insurer price transparency regulations, saying the rule is anti-competitive and could even force prices higher.
In written comments on the rule to CMS Administrator Seema Verma, health insurer trade groups said they agreed in principle that transparency is good, but the administration’s approach — released in its proposed rule last fall (HPW 11/25/19, p. 1) — is too heavy-handed. “The plans are not opposed to getting consumers the information that they need to make decisions about benefits,” says Dan Mendelson, Avalere founder and former CEO. “But there are a couple of issues here that are causing the plans to oppose this particular rule.”
© 2024 MMIT
Meet Our Reporters
-
Lauren Flynn Kelly Executive Editor, AIS Health, and Managing Editor, Radar on Medicare Advantage
View Lauren Flynn Kelly's Profile -
Angela Maas Managing Editor, Radar on Specialty Pharmacy and Spotlight on Market Access
View Angela Maas's Profile -
Leslie Small Managing Editor, Health Plan Weekly and Radar on Drug Benefits
View Leslie Small's Profile -
Peter Johnson Reporter, Health Plan Weekly and Radar on Drug Benefits
View Peter Johnson's Profile -
Tim Casey Reporter, Health Plan Weekly and Radar on Drug Benefits
View Tim Casey's Profile -
Carina Belles Reporter, Radar on Medicare Advantage and Spotlight on Market Access
View Carina Belles's Profile -
Jinghong Chen Reporter, Health Plan Weekly and Radar on Drug Benefits
View Jinghong Chen's Profile